For Companies

Research of novel medical technologies using the self-assembling peptide, our core technology, has been progressing in multiple fields. PuraMatrix™, the first-generation self-assembling peptide, has the excellent ability to regenerate tissues with high affinity for cells. Moreover, PuraMatrix™ has been nanostructured with high biodegradability and biocompatibility; therefore, it has gained a high reputation as a drug delivery system (DDS).

Field Examples of Research Results

Regenerative Medicine

Bone, myocardium, blood vessels, etc.

Cell Therapy

ES cells, mesenchymal stem cells, liver cells, neurons, osteoblasts, chondrocytes, vascular endothelial cells, etc.

Surgical Treatment

Wound healing, etc.

Drug Discovery Technology

Use as a drug delivery system (DDS) for proteins and peptides (BMP, PDGF, IGF-1, etc.)

Research Reagents

An exclusive distribution agreement with BD Biosciences (contract concluded)